Preoperative NSAID Use is Associated With a Small But Statistically Significant Increase in Blood Drainage in TLIF Procedures.

Nakatsuka, Michelle A; Kim, Yong; Protopsaltis, Themistocles; Fischer, Charla · Clin Spine Surg · 2025

retrospective_cohort · Level III

Where this comes from

Abstract

Retrospective analysis of retrospectively collected data. To determine the effects of preoperative nonsteroidal anti-inflammatory drug (NSAID) use on estimated blood loss (EBL) and postoperative drain output in TLIF procedures. Current standards of care recommend patients prescribed NSAIDs for chronic lower back pain discontinue NSAIDs at least 1 week before spine fusion surgery. The literature surrounding the effects of preoperative NSAID use is unclear, however, with dissonant findings regarding postoperative blood loss and complications. A retrospective case review was performed on 429 cases of 1-level or 2-level TLIF, with patient NSAID use recorded within 3 days of surgery, at a single institution. Linear and logistic regressions were used to assess associations between NSAID use, patient and surgical characteristics, EBL, and drain output. NSAID use was significantly positively associated with drain output ( P =0.03), with an approximate increase of 21±9.7 mL/day but no significant association with any postoperative complications ( P =0.77). Drain output also had significant, independent positive associations with patient age ( P =0.007), male sex ( P <0.001), and a number of levels fused ( P <0.001), and significant negative associations with robot-assisted ( P <0.001) and minimally invasive ( P =0.04) procedures. No significant association was detected between NSAID use and EBL ( P =0.21), though EBL had significant positive associations with operative time ( P <0.001) and levels fused ( P <0.001), and multiple NSAIDs had a significant positive association with EBL ( P <0.001). NSAID use had a statistically significant, but small, effect on drain output and no detectable effect on postoperative complications within 3 days of TLIF procedures, suggesting most patients can safely continue NSAID use up until their date of surgery. Future studies should further delineate the effects of preoperative NSAID use, such that a more refined risk profile could be developed from patient and surgical characteristics and NSAID use information.

Medical subject headings